- Home
- CDIO vs AMS Comparison
CDIO vs AMS Comparison
Compare CDIO & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- AMS
- Stock Information
- Founded
- CDIO 2017
- AMS 1980
- Country
- CDIO United States
- AMS United States
- Employees
- CDIO N/A
- AMS N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- AMS Medical Specialities
- Sector
- CDIO Health Care
- AMS Health Care
- Exchange
- CDIO Nasdaq
- AMS Nasdaq
- Market Cap
- CDIO 19.5M
- AMS 17.9M
- IPO Year
- CDIO N/A
- AMS N/A
- Fundamental
- Price
- CDIO $4.53
- AMS $2.98
- Analyst Decision
- CDIO Buy
- AMS
- Analyst Count
- CDIO 1
- AMS 0
- Target Price
- CDIO $2.00
- AMS N/A
- AVG Volume (30 Days)
- CDIO 68.6K
- AMS 7.0K
- Earning Date
- CDIO 05-23-2025
- AMS 05-15-2025
- Dividend Yield
- CDIO N/A
- AMS N/A
- EPS Growth
- CDIO N/A
- AMS 243.96
- EPS
- CDIO N/A
- AMS 0.33
- Revenue
- CDIO $34,890.00
- AMS $28,340,000.00
- Revenue This Year
- CDIO $1,434.82
- AMS $23.63
- Revenue Next Year
- CDIO $4,661.91
- AMS N/A
- P/E Ratio
- CDIO N/A
- AMS $8.76
- Revenue Growth
- CDIO 104.45
- AMS 32.90
- 52 Week Low
- CDIO $0.19
- AMS $2.51
- 52 Week High
- CDIO $1.77
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- CDIO 29.92
- AMS 61.91
- Support Level
- CDIO $4.50
- AMS $2.68
- Resistance Level
- CDIO $14.46
- AMS $2.80
- Average True Range (ATR)
- CDIO 1.69
- AMS 0.08
- MACD
- CDIO -0.97
- AMS 0.02
- Stochastic Oscillator
- CDIO 4.66
- AMS 94.12
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.